Gene-Chemical Interaction Annotations Click to see Annotation Detail View
Object Symbol | Species | Term | Qualifier | Evidence | With | Reference | Notes | Source | Original Reference(s) | Cyp2s1 | Rat | 1,2-dimethylhydrazine | decreases expression | ISO | Cyp2s1 (Mus musculus) | 6480464 | 1,2-Dimethylhydrazine results in decreased expression of CYP2S1 mRNA | CTD | PMID:22206623 | Cyp2s1 | Rat | 17alpha-ethynylestradiol | affects expression | ISO | Cyp2s1 (Mus musculus) | 6480464 | Ethinyl Estradiol affects the expression of CYP2S1 mRNA | CTD | PMID:17555576 | Cyp2s1 | Rat | 17alpha-ethynylestradiol | multiple interactions | ISO | Cyp2s1 (Mus musculus) | 6480464 | [Tetrachlorodibenzodioxin co-treated with Ethinyl Estradiol] results in increased expression of CYP2S1 mRNA | CTD | PMID:17942748 | Cyp2s1 | Rat | 17alpha-ethynylestradiol | increases expression | ISO | Cyp2s1 (Mus musculus) | 6480464 | Ethinyl Estradiol results in increased expression of CYP2S1 mRNA | CTD | PMID:17942748 | Cyp2s1 | Rat | 17beta-estradiol | increases expression | ISO | CYP2S1 (Homo sapiens) | 6480464 | Estradiol results in increased expression of CYP2S1 mRNA | CTD | PMID:21632981 | Cyp2s1 | Rat | 17beta-estradiol | multiple interactions | ISO | CYP2S1 (Homo sapiens) | 6480464 | [Estradiol co-treated with TGFB1 protein] results in decreased expression of CYP2S1 mRNA | CTD | PMID:30165855 | Cyp2s1 | Rat | 2,3,7,8-tetrachlorodibenzodioxine | multiple interactions | ISO | Cyp2s1 (Mus musculus) | 6480464 | [Tetrachlorodibenzodioxin co-treated with Ethinyl Estradiol] results in increased expression of CYP2S1 mRNA; AHR affects the more ... | CTD | PMID:17277313|PMID:17942748|PMID:21995607|PMID:28213091 | Cyp2s1 | Rat | 2,3,7,8-tetrachlorodibenzodioxine | increases expression | ISO | Cyp2s1 (Mus musculus) | 6480464 | Tetrachlorodibenzodioxin results in increased expression of CYP2S1 mRNA | CTD | PMID:17277313|PMID:17942748|PMID:19933214|PMID:21995607|PMID:23994337|PMID:28213091 | Cyp2s1 | Rat | 2,3,7,8-tetrachlorodibenzodioxine | increases expression | ISO | CYP2S1 (Homo sapiens) | 6480464 | Tetrachlorodibenzodioxin results in increased expression of CYP2S1 mRNA | CTD | PMID:22344700 | Cyp2s1 | Rat | 2,3,7,8-tetrachlorodibenzodioxine | affects expression | ISO | Cyp2s1 (Mus musculus) | 6480464 | Tetrachlorodibenzodioxin affects the expression of CYP2S1 mRNA | CTD | PMID:21570461 | Cyp2s1 | Rat | 2,3,7,8-tetrachlorodibenzodioxine | decreases expression | ISO | Cyp2s1 (Mus musculus) | 6480464 | Tetrachlorodibenzodioxin results in decreased expression of CYP2S1 mRNA | CTD | PMID:19770486 | Cyp2s1 | Rat | 2,3,7,8-tetrachlorodibenzodioxine | increases expression | EXP | | 6480464 | Tetrachlorodibenzodioxin results in increased expression of CYP2S1 mRNA | CTD | PMID:19883719 | Cyp2s1 | Rat | 2,4-dibromophenyl 2,4,5-tribromophenyl ether | affects expression | ISO | Cyp2s1 (Mus musculus) | 6480464 | 2,2',4,4',5-brominated diphenyl ether affects the expression of CYP2S1 mRNA | CTD | PMID:38648751 | Cyp2s1 | Rat | 2-hydroxypropanoic acid | affects expression | ISO | CYP2S1 (Homo sapiens) | 6480464 | Lactic Acid affects the expression of CYP2S1 mRNA | CTD | PMID:30851411 | Cyp2s1 | Rat | 2-naphthylamine | increases reduction | ISO | CYP2S1 (Homo sapiens) | 6480464 | CYP2S1 protein results in increased reduction of 2-Naphthylamine analog | CTD | PMID:23682735 | Cyp2s1 | Rat | 3,3',4,4',5-pentachlorobiphenyl | increases expression | ISO | Cyp2s1 (Mus musculus) | 6480464 | 3,4,5,3',4'-pentachlorobiphenyl results in increased expression of CYP2S1 mRNA | CTD | PMID:23994337 | Cyp2s1 | Rat | 3-methylcholanthrene | increases expression | EXP | | 6480464 | Methylcholanthrene results in increased expression of CYP2S1 mRNA | CTD | PMID:19883719 | Cyp2s1 | Rat | 4,4'-sulfonyldiphenol | increases expression | ISO | Cyp2s1 (Mus musculus) | 6480464 | bisphenol S results in increased expression of CYP2S1 mRNA | CTD | PMID:30951980 | Cyp2s1 | Rat | 4-hydroxyphenyl retinamide | decreases expression | ISO | Cyp2s1 (Mus musculus) | 6480464 | Fenretinide results in decreased expression of CYP2S1 mRNA | CTD | PMID:28973697 | Cyp2s1 | Rat | 5-fluorouracil | affects expression | ISO | Cyp2s1 (Mus musculus) | 6480464 | Fluorouracil affects the expression of CYP2S1 mRNA | CTD | PMID:20421339 | Cyp2s1 | Rat | 7,12-dimethyltetraphene | multiple interactions | ISO | CYP2S1 (Homo sapiens) | 6480464 | [CYP2S1 protein co-treated with cumene hydroperoxide] results in increased oxidation of 9,10-Dimethyl-1,2-benzanthracene | CTD | PMID:19713358 | Cyp2s1 | Rat | actinomycin D | multiple interactions | ISO | Cyp2s1 (Mus musculus) | 6480464 | Dactinomycin inhibits the reaction [Tetrachlorodibenzodioxin results in increased expression of CYP2S1 mRNA] | CTD | PMID:17277313 | Cyp2s1 | Rat | actinomycin D | multiple interactions | ISO | CYP2S1 (Homo sapiens) | 6480464 | [Dactinomycin co-treated with nutlin 3] results in increased expression of CYP2S1 protein | CTD | PMID:38460933 | Cyp2s1 | Rat | aflatoxin B1 | multiple interactions | ISO | CYP2S1 (Homo sapiens) | 6480464 | [CYP2S1 protein co-treated with cumene hydroperoxide] results in increased oxidation of Aflatoxin B1; [CYP2S1 protein more ... | CTD | PMID:19713358 | Cyp2s1 | Rat | aflatoxin B1 | increases expression | ISO | CYP2S1 (Homo sapiens) | 6480464 | Aflatoxin B1 results in increased expression of CYP2S1 mRNA | CTD | PMID:22100608 | Cyp2s1 | Rat | all-trans-retinoic acid | multiple interactions | ISO | CYP2S1 (Homo sapiens) | 6480464 | [CYP2S1 protein co-treated with cumene hydroperoxide] results in increased oxidation of Tretinoin; [CYP2S1 protein co-treated more ... | CTD | PMID:19713358 | Cyp2s1 | Rat | all-trans-retinoic acid | increases expression | ISO | CYP2S1 (Homo sapiens) | 6480464 | Tretinoin results in increased expression of CYP2S1 mRNA | CTD | PMID:12711469|PMID:16985168 | Cyp2s1 | Rat | all-trans-retinoic acid | increases metabolic processing | ISO | CYP2S1 (Homo sapiens) | 6480464 | CYP2S1 protein results in increased metabolism of Tretinoin | CTD | PMID:12711469 | Cyp2s1 | Rat | all-trans-retinoic acid | affects expression | ISO | Cyp2s1 (Mus musculus) | 6480464 | Tretinoin affects the expression of CYP2S1 mRNA | CTD | PMID:20421339 | Cyp2s1 | Rat | all-trans-retinoic acid | affects metabolic processing | ISO | CYP2S1 (Homo sapiens) | 6480464 | CYP2S1 protein affects the metabolism of Tretinoin | CTD | PMID:16054184 | Cyp2s1 | Rat | antirheumatic drug | decreases expression | ISO | CYP2S1 (Homo sapiens) | 6480464 | Antirheumatic Agents results in decreased expression of CYP2S1 mRNA | CTD | PMID:24449571 | Cyp2s1 | Rat | aristolochic acid A | increases expression | ISO | CYP2S1 (Homo sapiens) | 6480464 | aristolochic acid I results in increased expression of CYP2S1 mRNA | CTD | PMID:33212167 | Cyp2s1 | Rat | arsane | multiple interactions | ISO | CYP2S1 (Homo sapiens) | 6480464 | [[sodium arsenite results in increased abundance of Arsenic] co-treated with [manganese chloride results in increased more ... | CTD | PMID:39836092 | Cyp2s1 | Rat | arsenic atom | multiple interactions | ISO | CYP2S1 (Homo sapiens) | 6480464 | [[sodium arsenite results in increased abundance of Arsenic] co-treated with [manganese chloride results in increased more ... | CTD | PMID:39836092 | Cyp2s1 | Rat | atrazine | increases expression | EXP | | 6480464 | Atrazine results in increased expression of CYP2S1 mRNA | CTD | PMID:36841081 | Cyp2s1 | Rat | azathioprine | increases expression | ISO | CYP2S1 (Homo sapiens) | 6480464 | Azathioprine results in increased expression of CYP2S1 mRNA | CTD | PMID:22623647 | Cyp2s1 | Rat | Azoxymethane | multiple interactions | ISO | Cyp2s1 (Mus musculus) | 6480464 | [titanium dioxide co-treated with Azoxymethane co-treated with Dextran Sulfate] results in increased expression of CYP2S1 more ... | CTD | PMID:29950665 | Cyp2s1 | Rat | beclomethasone | decreases expression | ISO | CYP2S1 (Homo sapiens) | 6480464 | Beclomethasone results in decreased expression of CYP2S1 mRNA | CTD | PMID:22155357 | Cyp2s1 | Rat | benzo[a]pyrene | multiple interactions | ISO | CYP2S1 (Homo sapiens) | 6480464 | [[CYP2S1 protein co-treated with cumene hydroperoxide] results in increased oxidation of Benzo(a)pyrene] which results in more ... | CTD | PMID:19713358 | Cyp2s1 | Rat | benzo[a]pyrene | increases expression | ISO | Cyp2s1 (Mus musculus) | 6480464 | Benzo(a)pyrene results in increased expression of CYP2S1 mRNA | CTD | PMID:21995607 | Cyp2s1 | Rat | benzo[a]pyrene | increases expression | ISO | CYP2S1 (Homo sapiens) | 6480464 | Benzo(a)pyrene results in increased expression of CYP2S1 mRNA | CTD | PMID:21632981|PMID:22316170|PMID:32234424 | Cyp2s1 | Rat | benzo[a]pyrene | multiple interactions | ISO | Cyp2s1 (Mus musculus) | 6480464 | AHR affects the reaction [Benzo(a)pyrene results in increased expression of CYP2S1 mRNA]; AHR protein affects more ... | CTD | PMID:21995607|PMID:22228805 | Cyp2s1 | Rat | benzo[a]pyrene | decreases expression | ISO | Cyp2s1 (Mus musculus) | 6480464 | Benzo(a)pyrene results in decreased expression of CYP2S1 mRNA | CTD | PMID:19770486 | Cyp2s1 | Rat | benzo[a]pyrene diol epoxide I | increases expression | ISO | CYP2S1 (Homo sapiens) | 6480464 | 7,8-Dihydro-7,8-dihydroxybenzo(a)pyrene 9,10-oxide results in increased expression of CYP2S1 mRNA | CTD | PMID:20382639 | Cyp2s1 | Rat | Benzo[a]pyrene-7,8-diol | multiple interactions | ISO | CYP2S1 (Homo sapiens) | 6480464 | [[CYP2S1 protein co-treated with cumene hydroperoxide] results in increased oxidation of benzo(a)pyrene 7,8-dihydrodiol] which results more ... | CTD | PMID:19713358 | Cyp2s1 | Rat | beta-naphthoflavone | increases expression | ISO | Cyp2s1 (Mus musculus) | 6480464 | beta-Naphthoflavone results in increased expression of CYP2S1 mRNA | CTD | PMID:23994337 | Cyp2s1 | Rat | biphenyl-4-amine | increases reduction | ISO | CYP2S1 (Homo sapiens) | 6480464 | CYP2S1 protein results in increased reduction of 4-biphenylamine analog | CTD | PMID:23682735 | Cyp2s1 | Rat | bis(2-chloroethyl) sulfide | increases expression | ISO | CYP2S1 (Homo sapiens) | 6480464 | Mustard Gas results in increased expression of CYP2S1 mRNA | CTD | PMID:25102026 | Cyp2s1 | Rat | bisphenol A | decreases expression | EXP | | 6480464 | bisphenol A results in decreased expression of CYP2S1 mRNA | CTD | PMID:25181051 | Cyp2s1 | Rat | bisphenol A | increases expression | ISO | Cyp2s1 (Mus musculus) | 6480464 | bisphenol A results in increased expression of CYP2S1 mRNA | CTD | PMID:32156529|PMID:34585602 | Cyp2s1 | Rat | bisphenol A | increases expression | EXP | | 6480464 | bisphenol A results in increased expression of CYP2S1 mRNA | CTD | PMID:34947998 | Cyp2s1 | Rat | bisphenol A | affects expression | ISO | CYP2S1 (Homo sapiens) | 6480464 | bisphenol A affects the expression of CYP2S1 mRNA | CTD | PMID:36466761 | Cyp2s1 | Rat | bisphenol A | decreases expression | ISO | CYP2S1 (Homo sapiens) | 6480464 | bisphenol A results in decreased expression of CYP2S1 mRNA; bisphenol A results in decreased expression more ... | CTD | PMID:31715268|PMID:37567409 | Cyp2s1 | Rat | butanal | decreases expression | ISO | CYP2S1 (Homo sapiens) | 6480464 | butyraldehyde results in decreased expression of CYP2S1 mRNA | CTD | PMID:26079696 | Cyp2s1 | Rat | Butylbenzyl phthalate | increases methylation | ISO | Cyp2s1 (Mus musculus) | 6480464 | butylbenzyl phthalate results in increased methylation of CYP2S1 exon | CTD | PMID:28392331 | Cyp2s1 | Rat | Butylbenzyl phthalate | increases expression | ISO | Cyp2s1 (Mus musculus) | 6480464 | butylbenzyl phthalate results in increased expression of CYP2S1 mRNA | CTD | PMID:28392331 | Cyp2s1 | Rat | cadmium dichloride | increases expression | EXP | | 6480464 | Cadmium Chloride results in increased expression of CYP2S1 mRNA | CTD | PMID:33453195 | Cyp2s1 | Rat | calcitriol | decreases expression | ISO | CYP2S1 (Homo sapiens) | 6480464 | Calcitriol results in decreased expression of CYP2S1 mRNA | CTD | PMID:16002434 | Cyp2s1 | Rat | calcitriol | multiple interactions | ISO | CYP2S1 (Homo sapiens) | 6480464 | [Testosterone co-treated with Calcitriol] results in increased expression of CYP2S1 mRNA | CTD | PMID:21592394 | Cyp2s1 | Rat | calcitriol | increases expression | ISO | CYP2S1 (Homo sapiens) | 6480464 | Calcitriol results in increased expression of CYP2S1 mRNA | CTD | PMID:21592394|PMID:27107558 | Cyp2s1 | Rat | carbon nanotube | decreases expression | ISO | Cyp2s1 (Mus musculus) | 6480464 | Nanotubes, Carbon analog results in decreased expression of CYP2S1 mRNA; Nanotubes, Carbon results in decreased more ... | CTD | PMID:25554681 | Cyp2s1 | Rat | cisplatin | increases expression | ISO | CYP2S1 (Homo sapiens) | 6480464 | Cisplatin results in increased expression of CYP2S1 mRNA | CTD | PMID:27392435 | Cyp2s1 | Rat | cisplatin | multiple interactions | ISO | CYP2S1 (Homo sapiens) | 6480464 | [Cisplatin co-treated with jinfukang] results in increased expression of CYP2S1 mRNA | CTD | PMID:27392435 | Cyp2s1 | Rat | cortisol | decreases expression | ISO | CYP2S1 (Homo sapiens) | 6480464 | Hydrocortisone results in decreased expression of CYP2S1 mRNA | CTD | PMID:22155357 | Cyp2s1 | Rat | cumene hydroperoxide | multiple interactions | ISO | CYP2S1 (Homo sapiens) | 6480464 | [[CYP2S1 protein co-treated with cumene hydroperoxide] results in increased oxidation of benzo(a)pyrene 7,8-dihydrodiol] which results more ... | CTD | PMID:19713358 | Cyp2s1 | Rat | Cuprizon | decreases expression | EXP | | 6480464 | Cuprizone results in decreased expression of CYP2S1 mRNA | CTD | PMID:26577399 | Cyp2s1 | Rat | cyclosporin A | decreases expression | ISO | Cyp2s1 (Mus musculus) | 6480464 | Cyclosporine results in decreased expression of CYP2S1 mRNA | CTD | PMID:19770486 | Cyp2s1 | Rat | cyclosporin A | increases expression | ISO | CYP2S1 (Homo sapiens) | 6480464 | Cyclosporine results in increased expression of CYP2S1 mRNA | CTD | PMID:25562108 | Cyp2s1 | Rat | dexamethasone | decreases expression | ISO | CYP2S1 (Homo sapiens) | 6480464 | Dexamethasone results in decreased expression of CYP2S1 mRNA; Dexamethasone results in decreased expression of CYP2S1 more ... | CTD | PMID:22155357 | Cyp2s1 | Rat | dexamethasone | multiple interactions | ISO | CYP2S1 (Homo sapiens) | 6480464 | NR3C1 protein promotes the reaction [Dexamethasone results in decreased expression of CYP2S1 mRNA]; NR3C1 protein more ... | CTD | PMID:22155357 | Cyp2s1 | Rat | dextran sulfate | multiple interactions | ISO | Cyp2s1 (Mus musculus) | 6480464 | [titanium dioxide co-treated with Azoxymethane co-treated with Dextran Sulfate] results in increased expression of CYP2S1 more ... | CTD | PMID:29950665 | Cyp2s1 | Rat | diazinon | increases methylation | ISO | CYP2S1 (Homo sapiens) | 6480464 | Diazinon results in increased methylation of CYP2S1 gene | CTD | PMID:22964155 | Cyp2s1 | Rat | dibenz[a,h]anthracene | decreases expression | ISO | Cyp2s1 (Mus musculus) | 6480464 | 1,2,5,6-dibenzanthracene results in decreased expression of CYP2S1 mRNA | CTD | PMID:26377693 | Cyp2s1 | Rat | dioxygen | multiple interactions | ISO | CYP2S1 (Homo sapiens) | 6480464 | Oxygen affects the reaction [CYP2S1 protein results in increased reduction of 2-(4-amino-3-methylphenyl)-5-fluorobenzothiazole metabolite] | CTD | PMID:23682735 | Cyp2s1 | Rat | disodium selenite | decreases expression | ISO | CYP2S1 (Homo sapiens) | 6480464 | Sodium Selenite results in decreased expression of CYP2S1 mRNA | CTD | PMID:18175754 | Cyp2s1 | Rat | dorsomorphin | multiple interactions | ISO | CYP2S1 (Homo sapiens) | 6480464 | [NOG protein co-treated with entinostat co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression more ... | CTD | PMID:27188386 | Cyp2s1 | Rat | entinostat | multiple interactions | ISO | CYP2S1 (Homo sapiens) | 6480464 | [NOG protein co-treated with entinostat co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression more ... | CTD | PMID:27188386 | Cyp2s1 | Rat | entinostat | increases expression | ISO | CYP2S1 (Homo sapiens) | 6480464 | entinostat results in increased expression of CYP2S1 mRNA | CTD | PMID:26272509 | Cyp2s1 | Rat | etoposide | decreases expression | ISO | Cyp2s1 (Mus musculus) | 6480464 | Etoposide results in decreased expression of CYP2S1 mRNA | CTD | PMID:25270620 | Cyp2s1 | Rat | flunisolide | decreases expression | ISO | CYP2S1 (Homo sapiens) | 6480464 | flunisolide results in decreased expression of CYP2S1 mRNA | CTD | PMID:22155357 | Cyp2s1 | Rat | genistein | increases expression | ISO | Cyp2s1 (Mus musculus) | 6480464 | Genistein results in increased expression of CYP2S1 mRNA | CTD | PMID:32186404 | Cyp2s1 | Rat | glyphosate | affects methylation | EXP | | 6480464 | Glyphosate affects the methylation of CYP2S1 gene | CTD | PMID:35440735 | Cyp2s1 | Rat | hydrogen peroxide | multiple interactions | ISO | CYP2S1 (Homo sapiens) | 6480464 | [[CYP2S1 protein co-treated with Hydrogen Peroxide] results in increased oxidation of benzo(a)pyrene 7,8-dihydrodiol] which results more ... | CTD | PMID:19713358 | Cyp2s1 | Rat | hydroxylamine | multiple interactions | ISO | CYP2S1 (Homo sapiens) | 6480464 | [CYP2S1 protein results in increased reduction of Hydroxylamine] which results in increased chemical synthesis of more ... | CTD | PMID:22734839 | Cyp2s1 | Rat | hydroxylamine | increases reduction | ISO | CYP2S1 (Homo sapiens) | 6480464 | CYP2S1 protein results in increased reduction of Hydroxylamine | CTD | PMID:22734839 | Cyp2s1 | Rat | ivermectin | decreases expression | ISO | CYP2S1 (Homo sapiens) | 6480464 | Ivermectin results in decreased expression of CYP2S1 protein | CTD | PMID:32959892 | Cyp2s1 | Rat | manganese atom | multiple interactions | ISO | CYP2S1 (Homo sapiens) | 6480464 | [[sodium arsenite results in increased abundance of Arsenic] co-treated with [manganese chloride results in increased more ... | CTD | PMID:39836092 | Cyp2s1 | Rat | manganese(0) | multiple interactions | ISO | CYP2S1 (Homo sapiens) | 6480464 | [[sodium arsenite results in increased abundance of Arsenic] co-treated with [manganese chloride results in increased more ... | CTD | PMID:39836092 | Cyp2s1 | Rat | manganese(II) chloride | multiple interactions | ISO | CYP2S1 (Homo sapiens) | 6480464 | [[sodium arsenite results in increased abundance of Arsenic] co-treated with [manganese chloride results in increased more ... | CTD | PMID:39836092 | Cyp2s1 | Rat | methoxyacetic acid | affects expression | ISO | Cyp2s1 (Mus musculus) | 6480464 | methoxyacetic acid affects the expression of CYP2S1 mRNA | CTD | PMID:20421339 | Cyp2s1 | Rat | Monobutylphthalate | affects expression | ISO | Cyp2s1 (Mus musculus) | 6480464 | monobutyl phthalate affects the expression of CYP2S1 mRNA | CTD | PMID:20421339 | Cyp2s1 | Rat | naphthalene | affects metabolic processing | ISO | CYP2S1 (Homo sapiens) | 6480464 | CYP2S1 protein affects the metabolism of naphthalene | CTD | PMID:16054184 | Cyp2s1 | Rat | Nutlin-3 | multiple interactions | ISO | CYP2S1 (Homo sapiens) | 6480464 | [Dactinomycin co-treated with nutlin 3] results in increased expression of CYP2S1 protein | CTD | PMID:38460933 | Cyp2s1 | Rat | obeticholic acid | decreases expression | ISO | CYP2S1 (Homo sapiens) | 6480464 | obeticholic acid results in decreased expression of CYP2S1 mRNA | CTD | PMID:27939613 | Cyp2s1 | Rat | okadaic acid | increases expression | ISO | CYP2S1 (Homo sapiens) | 6480464 | Okadaic Acid results in increased expression of CYP2S1 mRNA | CTD | PMID:38832940 | Cyp2s1 | Rat | ozone | decreases expression | ISO | Cyp2s1 (Mus musculus) | 6480464 | Ozone results in decreased expression of CYP2S1 mRNA | CTD | PMID:12763052 | Cyp2s1 | Rat | ozone | multiple interactions | ISO | Cyp2s1 (Mus musculus) | 6480464 | [Air Pollutants results in increased abundance of Ozone] which results in decreased expression of CYP2S1 more ... | CTD | PMID:34911549 | Cyp2s1 | Rat | paracetamol | decreases expression | ISO | Cyp2s1 (Mus musculus) | 6480464 | Acetaminophen results in decreased expression of CYP2S1 mRNA | CTD | PMID:17585979 | Cyp2s1 | Rat | paracetamol | increases expression | EXP | | 6480464 | Acetaminophen results in increased expression of CYP2S1 mRNA | CTD | PMID:33387578 | Cyp2s1 | Rat | perfluorohexanesulfonic acid | decreases expression | ISO | Cyp2s1 (Mus musculus) | 6480464 | perfluorohexanesulfonic acid results in decreased expression of CYP2S1 mRNA | CTD | PMID:37995155 | Cyp2s1 | Rat | perfluorooctanoic acid | increases expression | ISO | CYP2S1 (Homo sapiens) | 6480464 | perfluorooctanoic acid results in increased expression of CYP2S1 protein | CTD | PMID:26879310 | Cyp2s1 | Rat | Pf-06840003 | multiple interactions | ISO | CYP2S1 (Homo sapiens) | 6480464 | PF-06840003 inhibits the reaction [APAF1 protein mutant form results in increased expression of CYP2S1 mRNA]; more ... | CTD | PMID:39172838 | Cyp2s1 | Rat | Pf-06840003 | multiple interactions | ISO | Cyp2s1 (Mus musculus) | 6480464 | PF-06840003 inhibits the reaction [[amyloid beta-protein (1-42) binds to MAPT protein] which results in increased more ... | CTD | PMID:39172838 | Cyp2s1 | Rat | pirinixic acid | decreases expression | ISO | Cyp2s1 (Mus musculus) | 6480464 | pirinixic acid results in decreased expression of CYP2S1 mRNA | CTD | PMID:17426115 | Cyp2s1 | Rat | pirinixic acid | multiple interactions | ISO | Cyp2s1 (Mus musculus) | 6480464 | [pirinixic acid binds to and results in increased activity of PPARA protein] which results in more ... | CTD | PMID:19710929 | Cyp2s1 | Rat | prednisolone | decreases expression | ISO | CYP2S1 (Homo sapiens) | 6480464 | Prednisolone results in decreased expression of CYP2S1 mRNA | CTD | PMID:22155357 | Cyp2s1 | Rat | quercetin | increases expression | ISO | CYP2S1 (Homo sapiens) | 6480464 | Quercetin results in increased expression of CYP2S1 mRNA | CTD | PMID:21632981 | Cyp2s1 | Rat | rac-lactic acid | affects expression | ISO | CYP2S1 (Homo sapiens) | 6480464 | Lactic Acid affects the expression of CYP2S1 mRNA | CTD | PMID:30851411 | Cyp2s1 | Rat | rifampicin | multiple interactions | ISO | CYP2S1 (Homo sapiens) | 6480464 | [Rifampin co-treated with NR1I2 protein] results in increased expression of CYP2S1 mRNA | CTD | PMID:21127053 | Cyp2s1 | Rat | SB 431542 | multiple interactions | ISO | CYP2S1 (Homo sapiens) | 6480464 | [LDN 193189 co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide co-treated with FGF2 protein] results in decreased expression of CYP2S1 more ... | CTD | PMID:27188386|PMID:37664457 | Cyp2s1 | Rat | silicon dioxide | decreases expression | ISO | CYP2S1 (Homo sapiens) | 6480464 | Silicon Dioxide analog results in decreased expression of CYP2S1 mRNA | CTD | PMID:25895662 | Cyp2s1 | Rat | silver atom | increases expression | ISO | Cyp2s1 (Mus musculus) | 6480464 | Silver results in increased expression of CYP2S1 mRNA | CTD | PMID:27131904 | Cyp2s1 | Rat | silver(0) | increases expression | ISO | Cyp2s1 (Mus musculus) | 6480464 | Silver results in increased expression of CYP2S1 mRNA | CTD | PMID:27131904 | Cyp2s1 | Rat | sodium arsenite | increases expression | ISO | CYP2S1 (Homo sapiens) | 6480464 | sodium arsenite results in increased expression of CYP2S1 mRNA | CTD | PMID:29301061|PMID:39719251 | Cyp2s1 | Rat | sodium arsenite | decreases expression | ISO | Cyp2s1 (Mus musculus) | 6480464 | sodium arsenite results in decreased expression of CYP2S1 mRNA | CTD | PMID:37682722 | Cyp2s1 | Rat | sodium arsenite | multiple interactions | ISO | CYP2S1 (Homo sapiens) | 6480464 | [[sodium arsenite results in increased abundance of Arsenic] co-treated with [manganese chloride results in increased more ... | CTD | PMID:39836092 | Cyp2s1 | Rat | succimer | multiple interactions | ISO | Cyp2s1 (Mus musculus) | 6480464 | [Succimer co-treated with Magnetite Nanoparticles] results in increased expression of CYP2S1 mRNA | CTD | PMID:26378955 | Cyp2s1 | Rat | tamoxifen | affects expression | ISO | Cyp2s1 (Mus musculus) | 6480464 | Tamoxifen affects the expression of CYP2S1 mRNA | CTD | PMID:17555576 | Cyp2s1 | Rat | testosterone | multiple interactions | ISO | CYP2S1 (Homo sapiens) | 6480464 | [Testosterone co-treated with Calcitriol] results in increased expression of CYP2S1 mRNA | CTD | PMID:21592394 | Cyp2s1 | Rat | testosterone | increases expression | ISO | CYP2S1 (Homo sapiens) | 6480464 | Testosterone results in increased expression of CYP2S1 mRNA | CTD | PMID:21592394 | Cyp2s1 | Rat | titanium dioxide | affects expression | ISO | Cyp2s1 (Mus musculus) | 6480464 | titanium dioxide affects the expression of CYP2S1 mRNA | CTD | PMID:23557971 | Cyp2s1 | Rat | titanium dioxide | multiple interactions | ISO | Cyp2s1 (Mus musculus) | 6480464 | [titanium dioxide co-treated with Azoxymethane co-treated with Dextran Sulfate] results in increased expression of CYP2S1 more ... | CTD | PMID:29950665 | Cyp2s1 | Rat | triamcinolone acetonide | decreases expression | ISO | CYP2S1 (Homo sapiens) | 6480464 | Triamcinolone Acetonide results in decreased expression of CYP2S1 mRNA | CTD | PMID:22155357 | Cyp2s1 | Rat | tributylstannane | increases expression | ISO | Cyp2s1 (Mus musculus) | 6480464 | tributyltin results in increased expression of CYP2S1 mRNA | CTD | PMID:31939706 | Cyp2s1 | Rat | trichostatin A | multiple interactions | ISO | CYP2S1 (Homo sapiens) | 6480464 | trichostatin A inhibits the reaction [Dexamethasone results in decreased expression of CYP2S1 mRNA] | CTD | PMID:22155357 | Cyp2s1 | Rat | tris(2-butoxyethyl) phosphate | affects expression | ISO | CYP2S1 (Homo sapiens) | 6480464 | tris(2-butoxyethyl) phosphate affects the expression of CYP2S1 mRNA | CTD | PMID:29024780 | Cyp2s1 | Rat | valproic acid | affects expression | ISO | Cyp2s1 (Mus musculus) | 6480464 | Valproic Acid affects the expression of CYP2S1 mRNA | CTD | PMID:20421339 | Cyp2s1 | Rat | valproic acid | increases expression | ISO | Cyp2s1 (Mus musculus) | 6480464 | Valproic Acid results in increased expression of CYP2S1 mRNA | CTD | PMID:21427059 | Cyp2s1 | Rat | valproic acid | increases expression | ISO | CYP2S1 (Homo sapiens) | 6480464 | Valproic Acid results in increased expression of CYP2S1 mRNA | CTD | PMID:23527032 | |






















